SHORT REPORTS
Loperamide and Ileostomy Output -Placebo-controlled Double-blind Crossover Study Loperamide,* a newly synthesized antidiarrhoeal agent more potent than diphenoxylate (Lomotil) 2 inhibits the peristalsis and the response to coaxial stimulation and nicotine in the isolated guinea-pig ileum, probably through a direct effect on nerve endings or intramural ganglia, or both.3 Tllhe present s(tudy was designed to analyse this inhibitory activity on human ,small intestinal peristalsis in vivo.
Materials and Methods
Twenty volunteers, aged 25-73, with well-established ileostomies for ulcerative colitis (13 patients), Crohn's disease (4) , colonic polyposis (2) , and colonic adenocarcinoma (1) , were asked to weigh their daily ileostomy output with a precision tubular balance, continuing their usual daily activities and diet. After a three-day drug-free period, they were allocated at random to either seven-day loperamide/seven-day placebo sequence or the reverse.
Each patient was given a bottle with 2-mg loperamide capsules and a bottle with identical looking placebo capsules for each treatment period and was asked to take two capsules twice a day for the first four days and, if needed, to adapt the daily dose to six capsules for the remaining three days of each period. Non-parametric tests4 were used for statistical evaluatien.
Results and Discussion
The median and range of the daily faecal weights were 645 (100-2620), 500 The differentiation of pancreatic carcinoma from chronic pancreatitis may prove impossible even at operation. Having heard that carcinoembryonic antigen (C.E.A.) levels were nearly always raised in pancreatic cancers1 2 we investigated both C.E.A. levels and Lundh test results as a means of differentiating these two conditions. Methods, Patients, and Results Plasma C.E.A. was measured by a modified double antibody technique3 Pancreatic exocrine function was estimated by the Lundh test4 in all 2.5 patients with chronic pancreatitis and 10 of the 12 patients with carcinoma of the pancreas. Patients with chronic pancreatitis showed at least three of the following features: pancreatic calcification on abdominal x-ray films; a mean trypic activity (M.T.A.) in duodenal juice after a Lundh test meal 66 IU/mt4; at least one well-documented attack of acute pancreatitis with serum amylase> 100 IU/l; diagnosis of chronic pancreatitis at laparotomy; history of chronic pancreatitis of three or more years. Pancreatic carcinoma was diagnosed at operation within two weeks of C.E.A. and duodenal M.T.A. determinations. In six patients histological confirmation was not obtained. The tumour was apparently confined to the pancreas in four, and either extended beyond the pancreas or had metastasized in eight.
Ten patients with pancreatitis but none with carcinoma had normal plasma C.E.A. levels (612-5 ±tg/l; x' = 6 95; P<001). No patients with pancreatitis had C.E.A. levels above 40 ug/l compared with five of those with carcinoma (x= 12-27; P<0 001). The two diseases overlapped from 12-5 to 40 ,ug/l and only one of the four patients with localized carcinoma had a level greater than 40 jug/l. 
